Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines

Author:

Kara Aytug,Vassiliadou Athina,Ongoren Baris,Keeble William,Hing Richard,Lalatsa AikateriniORCID,Serrano Dolores R.ORCID

Abstract

Currently, there is an unmet need to manufacture nanomedicines in a continuous and controlled manner. Three-dimensional (3D) printed microfluidic chips are an alternative to conventional PDMS chips as they can be easily designed and manufactured to allow for customized designs that are able to reproducibly manufacture nanomedicines at an affordable cost. The manufacturing of microfluidic chips using existing 3D printing technologies remains very challenging because of the intricate geometry of the channels. Here, we demonstrate the manufacture and characterization of nifedipine (NFD) polymeric nanoparticles based on Eudragit L-100 using 3D printed microfluidic chips with 1 mm diameter channels produced with two 3D printing techniques that are widely available, stereolithography (SLA) and fuse deposition modeling (FDM). Fabricated polymeric nanoparticles showed good encapsulation efficiencies and particle sizes in the range of 50–100 nm. SLA chips possessed better channel resolution and smoother channel surfaces, leading to smaller particle sizes similar to those obtained by conventional manufacturing methods based on solvent evaporation, while SLA manufactured nanoparticles showed a minimal burst effect in acid media compared to nanoparticles fabricated with FDM chips. Three-dimensional printed microfluidic chips are a novel and easily amenable cost-effective strategy to allow for customization of the design process for continuous manufacture of nanomedicines under controlled conditions, enabling easy scale-up and reducing nanomedicine development times, while maintaining high-quality standards.

Funder

Complutense University of Madrid

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference48 articles.

1. Nanomedicine: An ESF-European Medical Councils (EMRC) forword look report;Kreyling;Strasbg. Cedex,2005

2. Nanomedicine Market Size Worth $350.8 Billion by 2025–GR: 11.2%https://www.grandviewresearch.com/press-release/global-nanomedicine-market#:~:text=The%20global%20nanomedicine%20market%20is,more%20cost%2Deffective%20than%20traditional

3. COVID-19 vaccine development and a potential nanomaterial path forward

4. Progress in nanomedicine: Approved and investigational nanodrugs;Ventola;Pharm. Ther.,2017

5. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3